IP Library Granted Patent US 7,033,792
Granted Patent B2
US 7,033,792 · App. 10/143,575 · Granted Apr 25, 2006

Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,033,792
App. No.
10/143,575
Granted
Apr 25, 2006
Kind
B2
Abstract

The present invention provides amino acid sequences of peptides that are encoded by genes within the human genome, the secreted peptides of the present invention. The present invention specifically provides isolated peptide and nucleic acid molecules, methods of identifying orthologs and paralogs of the secreted peptides, and methods of identifying modulators of the secreted peptides.

Claims (13)

1. An isolated nucleic acid molecule, wherein the nucleotide sequence of said nucleic acid molecule consists of a nucleotide sequence selected from the group consisting of:

(a) a nucleotide sequence that encodes a polypeptide having an amino acid sequence comprising SEQ ID NO:2 except that residue 222 is glutamine;

(b) a nucleotide sequence consisting of SEQ ID NO:1 except that nucleotide 665 is adenine;

(c) a nucleotide sequence consisting of SEQ ID NO:3 except that nucleotide 10319 is adenine; and

(d) a nucleotide sequence that is completely complementary to a nucleotide sequence of (a)–(c).

2. A vector comprising the nucleic acid molecule of claim 1 .

3. An isolated host cell containing the vector of claim 2 .

4. A process for producing a polypeptide comprising culturing an isolated host cell under conditions sufficient for the production of said polypeptide, wherein said host cell comprises a vector which comprises the nucleic acid of a), b) or c) of claim 1 , and recovering said polypeptide.

5. An isolated polynucleotide, wherein the nucleotide sequence of said polynucleotide consists of SEQ ID NO:1 except that nucleotide 665 is adenine; or the complete complement of said nucleotide sequence.

6. An isolated polynucleotide, wherein the nucleotide sequence of said polynucleotide consists of SEQ ID NO:3 except that nucleotide 10319 is adenine, or the complete complement of said nucleotide sequence.

7. The vector of claim 2 , wherein said vector is selected from the group consisting of a plasmid, a virus, and a bacteriophage.

8. The vector of claim 2 , wherein said isolated nucleic acid molecule is inserted into said vector in proper orientation and correct reading frame such that a polypeptide is expressed by a cell transformed with said vector, wherein said polypeptide has an amino acid sequence comprising SEQ ID NO:2 except that residue 222 is glutamine.

9. The vector of claim 8 , wherein said isolated nucleic acid molecule is operatively linked to a promoter sequence.

Assignments (3)
CHANGE OF NAME Recorded Feb 26, 2010
From: APPLERA CORPORATION
To: APPLIED BIOSYSTEMS INC.
Reel/Frame 023994/0538 →
MERGER Recorded Feb 26, 2010
From: APPLIED BIOSYSTEMS INC.
To: APPLIED BIOSYSTEMS, LLC
Reel/Frame 023994/0587 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2008
From: APPLERA CORPORATION
To: CELERA CORPORATION
Reel/Frame 021561/0124 →